During Wednesday’s House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade’s 300% price increase, frustrating congressional representatives.
from WebMD Health https://wb.md/2G9mhX4
0 comments:
Post a Comment